BioHarvest Sciences Inc.
BHST
Positions held
Your positionsBHST isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $33.89M | Enterprise value | $33.36M | Trailing P/E | — | Forward P/E | -4.46 |
| PEG | — | Price / book | 1.71 | Beta | 1.38 | Dividend yield | 0.00% |
| Revenue growth | 3.8% | Earnings growth | — | Gross margin | 59.0% | Operating margin | -28.4% |
| Profit margin | -31.2% | ROE | -142.5% | ROA | -11.0% | Debt / equity | 0.79 |
| Current ratio | 2.24 | Free cash flow | -$11.85M | Analyst recommendation | none | Mean target | $10.50 |
| 52w high | $12.80 | 52w low | $1.37 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $8.8M | $8.5M | $9.1M | $9.1M | $8.5M | — |
| Op margin | -28.4% | -21.6% | -12.4% | -10.1% | -21.3% | — |
| Net income | -$3.7M | -$2.6M | -$2.2M | -$2.5M | -$4.1M | — |
| Gross margin | 57.5% | 59.2% | 57.6% | 61.4% | 59.7% | — |
| Gross profit | $5.1M | $5.0M | $5.2M | $5.6M | $5.1M | — |
| Operating income | -$2.5M | -$1.8M | -$1.1M | -$0.9M | -$1.8M | — |
- Revenue +4% vs prior quarter ($8.8M vs $8.5M).
- Gross margin 57.5% (was 59.2% prior quarter).
- Operating margin compressed to -28.4%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $34.5M | $25.2M | $12.7M | $5.5M | — |
| Op margin | -16.2% | -27.7% | -78.6% | -193.0% | — |
| Net income | -$11.1M | -$12.9M | -$12.6M | -$11.2M | — |
| Gross margin | 59.3% | 55.4% | 44.5% | 22.2% | — |
| Gross profit | $20.5M | $13.9M | $5.6M | $1.2M | — |
| Operating income | -$5.6M | -$7.0M | -$10.0M | -$10.6M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · BioHarvest says its platform can produce target sweetener in Tate & Lyle program
2026-10-08 · Tate & Lyle and Bioharvest Reach Key Milestone in Next-Generation Sweetener Development Programme
2026-09-29 · BioHarvest Sciences launches buyback of up to 5% of shares
2026-09-29 · BioHarvest Sciences Announces Share Repurchase Program
2026-09-15 · BioHarvest Sciences launches single-dose VINIA Daily Chews
2026-09-14 · BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-03 · BioHarvest Sciences plans Tel Aviv Stock Exchange dual listing
2026-09-03 · BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
2026-08-31 · Q3 Virtual Investor Summit Presentations Now Available On Demand
2026-08-24 · Investor Summit | MicroCap Opportunities to Watch - August 26
2026-08-12 · BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript
Price (daily)
Full chart · RSI · MACD · patterns